37 related articles for article (PubMed ID: 38739587)
1. Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.
Jordan CA; Sandoval BA; Serobyan MV; Gilling DH; Groziak MP; Xu HH; Vey JL
Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1521-30. PubMed ID: 26625295
[TBL] [Abstract][Full Text] [Related]
2. Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).
Mehboob S; Song J; Hevener KE; Su PC; Boci T; Brubaker L; Truong L; Mistry T; Deng J; Cook JL; Santarsiero BD; Ghosh AK; Johnson ME
Bioorg Med Chem Lett; 2015 Mar; 25(6):1292-6. PubMed ID: 25677657
[TBL] [Abstract][Full Text] [Related]
3. Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.
Mehboob S; Hevener KE; Truong K; Boci T; Santarsiero BD; Johnson ME
J Med Chem; 2012 Jun; 55(12):5933-41. PubMed ID: 22642319
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.
Mahnashi MH; Avunoori S; Gopi S; Shaikh IA; Saif A; Bantun F; Faidah HS; Alhadi AA; Alshehri JH; Alharbi AA; S R PK; Joshi SD
PLoS One; 2024; 19(5):e0303173. PubMed ID: 38739587
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide-Hydrazone and Thiadiazole Derivatives Targeting InhA.
Teneva Y; Simeonova R; Valcheva V; Angelova VT
Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111241
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Molecular Docking Study, and Biological Evaluation of New 4-(2,5-Dimethyl-1
Mahnashi MH; Koganole P; S R PK; Ashgar SS; Shaikh IA; Joshi SD; Alqahtani AS
Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107123
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells.
Yao J; Takenaga K; Koshikawa N; Kida Y; Lin J; Watanabe T; Maru Y; Hippo Y; Yamamoto S; Zhu Y; Nagase H
Int J Cancer; 2023 Mar; 152(5):962-976. PubMed ID: 36214789
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Antimicrobial Potential and Toxicity of a Newly Synthesised 4-(4-(Benzylamino)butoxy)-9
Zawadzka K; Felczak A; Głowacka IE; Piotrowska DG; Lisowska K
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884610
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-
Venugopala KN; Uppar V; Chandrashekharappa S; Abdallah HH; Pillay M; Deb PK; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Tratrat C; Yousef Jaber A; Venugopala R; Mailavaram RP; Al-Jaidi BA; Kandeel M; Haroun M; Padmashali B
Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32392709
[TBL] [Abstract][Full Text] [Related]
10. ADMET properties of novel 5-O-benzoylpinostrobin derivatives.
Pratama MRF; Poerwono H; Siswodiharjo S
J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31851612
[TBL] [Abstract][Full Text] [Related]
11. Application of the SwissDrugDesign Online Resources in Virtual Screening.
Daina A; Zoete V
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540350
[TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis and in silico molecular modeling of novel pyrrolyl benzohydrazide derivatives: Their biological evaluation against enoyl ACP reductase (InhA) and Mycobacterium tuberculosis.
Joshi SD; More UA; Dixit SR; Balmi SV; Kulkarni BG; Ullagaddi G; Lherbet C; Aminabhavi TM
Bioorg Chem; 2017 Dec; 75():181-200. PubMed ID: 28961440
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antimycobacterial activity and docking study of 2-aroyl-[1]benzopyrano[4,3-c]pyrazol-4(1H)-one derivatives and related hydrazide-hydrazones.
Angelova VT; Valcheva V; Pencheva T; Voynikov Y; Vassilev N; Mihaylova R; Momekov G; Shivachev B
Bioorg Med Chem Lett; 2017 Jul; 27(13):2996-3002. PubMed ID: 28512022
[TBL] [Abstract][Full Text] [Related]
14. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.
Daina A; Michielin O; Zoete V
Sci Rep; 2017 Mar; 7():42717. PubMed ID: 28256516
[TBL] [Abstract][Full Text] [Related]
15. N-substituted pyrrole-based scaffolds as potential anticancer and antiviral lead structures.
Pegklidou K; Papastavrou N; Gkizis P; Komiotis D; Balzarini J; Nicolaou I
Med Chem; 2015; 11(6):602-8. PubMed ID: 25770917
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
17. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Diacon AH; Donald PR; Pym A; Grobusch M; Patientia RF; Mahanyele R; Bantubani N; Narasimooloo R; De Marez T; van Heeswijk R; Lounis N; Meyvisch P; Andries K; McNeeley DF
Antimicrob Agents Chemother; 2012 Jun; 56(6):3271-6. PubMed ID: 22391540
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of XDR TB cases--a retrospective study from a tertiary care TB hospital.
Myneedu VP; Visalakshi P; Verma AK; Behera D; Bhalla M
Indian J Tuberc; 2011 Apr; 58(2):54-9. PubMed ID: 21644390
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
